MARKET

AVGR

AVGR

Avinger
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2770
-0.0042
-1.49%
After Hours: 0.2760 -0.001 -0.36% 17:16 01/24 EST
OPEN
0.2600
PREV CLOSE
0.2812
HIGH
0.2800
LOW
0.2464
VOLUME
2.49M
TURNOVER
--
52 WEEK HIGH
2.670
52 WEEK LOW
0.2464
MARKET CAP
26.47M
P/E (TTM)
-1.1965
1D
5D
1M
3M
1Y
5Y
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device Designation for the treatment of chronic chemo induced peripheral neuropathy with its wearable neurostimulation technology.
Benzinga · 6d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Avinger (NASDAQ:AVGR) stock moved upwards by 9.7% to $0.34 during Friday's after-market session. This security traded at a volume of 1.2 million shares come close, making up 60.0% of its average volume over the last 100 days. The company's market c...
Benzinga · 01/14 21:31
Avinger Announces Closing of $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 14, 2022 / Avinger, Inc. The shares of Preferred Stock have a stated value of $1,000 per share and are convertible into an aggregate of 19,000,000 shares of common stock at a conversion price of $0.
ACCESSWIRE · 01/14 21:01
Avinger plunges on stock offering to raise $7.6M capital
Avinger (NASDAQ:AVGR) plunges 23% in premarket trade after entering into a definitive agreement with certain institutional investors for the issuance and sale in a registered direct offering of 7.6K shares of Series D
Seekingalpha · 01/12 13:23
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Benzinga · 01/12 13:22
Avinger Announces $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. The shares of Preferred Stock will have a stated value of $1,000 per share and are convertible into an aggregate of 19,000,000 shares of common stock at a conversion price of $0.
ACCESSWIRE · 01/12 13:00
BRIEF-Avinger Announces 510(K) Clearance For Lightbox 3 Next-Generation
reuters.com · 01/11 13:58
Avinger Press Release Confirms 510(k) Clearance For Lightbox 3 Imaging Console
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today
Benzinga · 01/11 13:34
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVGR. Analyze the recent business situations of Avinger through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AVGR stock price target is 2.250 with a high estimate of 2.500 and a low estimate of 2.000.
High2.500
Average2.250
Low2.000
Current 0.2770
EPS
Actual
Estimate
-0.06-0.04-0.03-0.01
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 48
Institutional Holdings: 11.75M
% Owned: 12.30%
Shares Outstanding: 95.56M
TypeInstitutionsShares
Increased
5
560.68K
New
8
567.55K
Decreased
6
19.10K
Sold Out
5
487.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.50%
Healthcare Equipment & Supplies
-0.18%
Key Executives
Non-Executive Chairman/Independent Director
James Cullen
President/Chief Executive Officer/Director
Jeffrey Soinski
Chief Financial Officer
Mark Weinswig
Chief Technology Officer
Himanshu Patel
Independent Director
Tamara Elias
Independent Director
James McElwee
No Data
About AVGR
Avinger, Inc. is a commercial-stage medical device company. The Company is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The Company operates through Lumivascular technology platform. Its Lumivascular platform integrates optical coherence tomography (OCT) visualization with interventional catheters that provides real-time intravascular imaging simultaneously with treatment in PAD procedures. It also consists of a capital component, Lightbox, and a variety of disposable catheter products, including the Ocelot and Pantheris family of catheters. The Company's Lightbox is a video imaging console, which enables the use of Lumivascular catheters during PAD procedures. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure.

Webull offers kinds of Avinger Inc stock information, including NASDAQ:AVGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVGR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVGR stock methods without spending real money on the virtual paper trading platform.